Get 50% OFF This Summer!

Advertisement
AdvertisementAdvertisement
logo

Zydus Wellness

ZYDUSWELL
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Zydus Wellness Share price and Fundamental Analysis

View All Details
View All Details
Headquartered in Ahmedabad, Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company's product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite. It has five manufacturing operations- one each at Ahmedabad (Gujarat), Aligarh (Uttar Pradesh), Sitarganj (Uttarakhand) and two at Mamring (Sikkim). It enjoys a pan-India marketing presence through a distribution network comprising 1700+ distributors and ~2000 feet-on-street representatives. The Company's distribution competence has been facilitated by investment in 24 integrated warehouses, which can serve both its cold chain and ambient range of brands.
Company Incorporation1994
ChairmanSharvil P Patel
Head QuartersAhmedabad
Previous NameNA

Key Metrics

Market Cap (Cr)
12,399
PE Ratio
36.34
Industry P/E
39.56
PEG Ratio
1.31
ROE
6.12%
ROCE
6.33%
ROA
5.39%
Total Debt (Cr)
129.6
Debt to Equity
0.03
Dividend Yield
0.31%
EPS
53.62
Book Value & P/B
634.06 x 3.07
Face Value
10
Outstanding Shares(Cr)
6.36
Current Ratio
1.98
EV to Sales
4.65

Included In

+More

Stock Returns

1 Week+8.84%
1 Month+11.08%
6 Months+2.4%
1 Year+14.33%
3 Years+28.4%
5 Years+56.44%

CAGR

1 Year CAGR

Revenue Growth

+3.24%

Net Profit Growth

-14.01%

Operating Profit Growth

-7.25%

Dividend Growth

0%

Stock Returns CAGR

+12.05%
no_data

No Stocks

Smart Score

2.8
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 69.63%

FIIs : 3.29%

DIIs : 19.76%

Public : 7.31%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
Promoter Shareholding Increased by 0.02% to 69.63% in March 2025 Qtr
FII Shareholding Decreased by 0.08% to 3.29% in March 2025 Qtr
DII Shareholding Decreased by 0.36% to 19.76% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Zydus Wellness Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Zydus Wellness Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Headquartered in Ahmedabad, Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The Company's product portfolio includes popular brands with functional benefits like Glucon D, Complan, Sugar Free, Nycil, Everyuth, Nutralite and Sugarlite. It has five manufacturing operations- one each at Ahmedabad (Gujarat), Aligarh (Uttar Pradesh), Sitarganj (Uttarakhand) and two at Mamring (Sikkim). It enjoys a pan-India marketing presence through a distribution network comprising 1700+ distributors and ~2000 feet-on-street representatives. The Company's distribution competence has been facilitated by investment in 24 integrated warehouses, which can serve both its cold chain and ambient range of brands.

Zydus Wellness Ltd was incorporated on November 1, 1994 as a public limited company with the name Carnation Health Foods Ltd. The company set up a unit to manufacture Low fat, Zero cholesterol Margarine as a Butter substitute and Low fat, Zero Cholesterol Cheese and casienate and milk fat.

The name of the company was changed from Carnation Health Foods Ltd to Carnation Nutra-Analogue Foods. In December 15, 1996, the company started trial runs in their manufacturing unit and in January 1997, they started commercial production activity. During the year 1997-98, they set up their marketing channel for the State of Gujarat.

During the year 2005-06, the company increased the production capacity of Margarine from 3928 MT to 5500 MT. Cadila Healthcare, a listed public limited company acquired 3432138 equity shares through market purchase and open offer.

During the year 2006-07, the company launched a variant of Nutralite in retail under the brand 'Nutralite Premium' and increased production capacity of Margarine from 5500 MT to 8500 MT in 2007-08.

During the year 2008-09, as per the scheme of arrangement, the consumer products division of Cadila Healthcare Ltd, the holding company was de-merged and transferred to the company with effect from April 1, 2008. In January 5, 2009 the name of the company was changed from Carnation Nutra-Analogue Foods Ltd to Zydus Wellness Ltd, in order to recognize them as 'Zydus Cadila' Group Company.

During the year, the company increased the production of Nutraceuticals from 8500 tonnes to 14600 tones. They launched a power brand 'Natura Diet Sugar' to bring convenience to the consumer.

During the year 2009-10, the equity shares of the company were listed on National Stock Exchange of India Ltd with effect from November 13, 2009. They launched Sugar Free Natura Flavored sachets in Lemon Mint and Ginger Masala flavours to enhance the consumer experience and offer a wider choice to the customers. In September 2010, the company extended their niche product basket with the launch of Sugar Free Mints.

During the year 2013-14, both variants of Sugar Free, the aspartame based Sugar Free Gold and sucralose based Sugar Free Natura, continued to lead in their respective segments.

In the Facial Mask category, EverYuth launched 3 in 1 Neem Face Pack in FY 2014-15.

In the Peel Off segment the Company drove the category single-handedly and expanded the portfolio through the launch of a new 'Fairness Peel Off' with Intelligent Target Delivery Whitening Technology, a first in India. This launch was supported with a new multimedia campaign across TV, print and digital and the initial results have been encouraging.

The Company has launched a new and innovative 'Tulsi Turmeric Face Wash' at an attractive consumer price appealing to young women seeking high performance products at affordable prices.

In the Nutralite segment, a new variant called Nutralite Yummy' was launched in the retail segment in North India, positioned on the platform of Great Taste at Great Value. This launch was supported through local media and sampling programs as well as in-store activation.

In 2014, the skin-cleansing category continued with a slower growth rate, putting pressure on the Everyuth franchise. Everyuth maintained its leadership position in the Mask and Scrub segments by driving integrated campaigns across multiple mediums. During the year, the Company introduced Stevia, a new variant of Sugar Free in limited markets.

The Company strengthened its margarine product portfolio by introducing Nutralite with Omega 3 benefits. This has further helped build equity of Nutralite amongst health conscious consumers.

Everyuth continues to face stiff competition in the highly competitive Face Wash category. In keeping with its tradition of launching innovative products and formats, the Company launched a 'Sachet pack of EverYuth Tulsi Turmeric face wash', which is a first in India and is intended to provide convenience and better access to the consumer.

Capital expenditure during the year 2014-15 was Rs. 31 million.

During the year 2015-16, to address the challenges in the Face Wash segment, Everyuth re-launched its Face Wash range with fresh, new and contemporary looking packaging in March 16. This re-launch will be supported by communication across mediums. Focus in 2015-16 was also to further strengthen the Everyuth Tulsi- Turmeric variant in the market.

During the year 2015-16, the Company saw stabilization of its revamped distribution system in the later part of the year gone by. The company rolled out distribution expansion program named 'EnReach' during the year, which has resulted into a significant growth in the direct coverage. Through this program, channel wise thrust was provided to strengthen the brand presence across general trade, modern trade and Hotel/Restaurants/Caterers (HORECA) segments.

During the FY 2016-17, in the Face Wash segment, Everyuth reported growth revival following the re-launch of the Face Wash range with fresh, new and contemporary looking packaging. During the last quarter of the financial year, the Tulsi Turmeric' Face wash was re-launched with improved product and packaging.

The company strengthened the distribution system during the last financial year. The company rolled out a program named 'EnReach 2.0' to drive the next wave of distribution expansion focused on enhancing quality of direct reach. Through this program, a channel-wise thrust helped strengthen brand presence across the general trade, modern trade and Hotel/ Restaurants / Caterers (HORECA) segments.

To build the international business, the Company entered new markets like Saudi Arabia, Qatar, Oman and Myanmar.

Zydus Wellness reported an improvement in the growth rates of all brands viz. Sugar Free, Everyuth & Nutralite in 2017-18. Its flagship portfolio maintained leadership across respective categories in 2017-18.

The Company collaborated with popular news channel NDTV on World Health Day to telecast 'Sugar Free &150; Health For All' program which presented Sugar Free as a safe alternative to sugar.

In the Everyuth skin-cleansing category, the company re-launched the Golden glow peel off with new packaging with support from media activities and TV campaign in 2017-18.

In the Scrub segment, the company launched Neem Papaya scrub in May 2017 for problem-prone skin, which was backed by a new TV campaign in August 2017. In the Face Wash segment, a new advertising campaign was launched to support the Tulsi Turmeric face wash from May.

For Nutralite brand, the company continued to use the digital platform innovatively with digital initiatives like 'Facebook live' (live with Chef Sanjeev Kapoor), 'KhaneMe Twist' campaign and Nutralite healthy recipes campaign on Shilpa Shetty's digital assets.

The company launched Nutralite Mayonnaise in three flavors for the retail segment in January 2018. This will be supported with Print, TV; digital and on-ground activation campaigns.

During the year under review, Zydus Wellness continued its effort to enhance distribution both in terms of numeric reach as well as depth of products available through the financial year 2017-18. Significant focuses were given to direct distribution of new launches and strategic SKUs (stock keeping units) within the existing portfolio.

In an effort to build its international business, the company entered new markets like Tanzania and South Africa and enhanced its portfolio with the launch of Nutralite in Middle East countries like Oman and UAE during FY 2017-18.

In 2017-18, Zydus Wellness incurred capital expenditure aggregating Rs 99.6 million.

During the year 2019, the company had entered into a Share Purchase Agreement jointly with Cadila Healthcare Limited to acquire 100% shareholding of Heinz India Private Limited, (Heinz). The Company along with its wholly owned entity Zydus Wellness - Sikkim, paid a consideration amount of Rs 4,667.36 Crores (which includes payment towards cash and bank balance of Rs 125 Crores in Heinz and acquired 100% shareholding of Heinz.

During the year 2019, the Company has issued and allotted 1,85,92,055 Equity Shares of face value of Rs 10/- each at a price of Rs 1,385/- (including a premium of Rs 1,375/-) per equity share to Threpsi Care LLP,

Pioneer Investments Fund, Cadila Healthcare Limited and Zydus Family Trust. The above shares were issued and allotted by way of preferential issue under Chapter VII of Securities and Exchange Board of India (Issue of Securities and Disclosure Requirements) Regulations, 2018 ('SEBI ICDR') on January 29, 2019.

During FY 2018-19, the Company incorporated two wholly owned subsidiaries in the name of Liva Nutritions Limited on December 21, 2018 and Liva Investment Limited on December 24, 2018. The Company also invested an amount of Rs 5,00,000/- and Rs 25,00,000/- by subscribing to the Memorandum and Articles of Association of Liva Nutritions Limited and Liva Investment Limited, respectively.

In FY 2018-19, the existing group entity M/s. Zydus Wellness, Sikkim (ZWS), a Partnership Firm, which was under the majority control of the Company, was converted into a Public Limited Company in the name of Zydus Nutritions Limited (ZNL) on February 28, 2019 under chapter XXI of the Companies Act, 2013.

During the year under review, a Scheme of Amalgamation of Heinz with ZNL was filed with the Hon'ble National Company Law Tribunal; Bench at Ahmedabad and the same was approved on May 10, 2019 and made Effective from May 24, 2019. In view of the same, HIPL got merged into ZNL and ceased to be subsidiary from the Appointed Date i.e. March 1, 2019.

During the year 2019, the Company had issued equity shares to Cadila Healthcare Limited and Zydus Family Trust as per the resolutions passed by the shareholders at the Extra Ordinary General Meeting held on January 4, 2019.

Pursuant to the definitive agreement entered into by the Company on October 24, 2018 to acquire Heinz India Private Ltd. [HIPL], the Company and its wholly owned entity, M/s. Zydus Wellness - Sikkim [a partnership firm]- have completed the acquisition of HIPL on January 30, 2019.

Pursuant to the Scheme of Amalgamation between the two subsidiaries of the Company viz. ZNL and HIPL, sanctioned by the Ahmedabad bench of Hon'able National Company Law Tribunal [NCLT] vide its order dated May 10, 2019 and effective date being May 24, 2019, HIPL merged with ZNL with effect from the appointed date of March 1, 2019.

In 2018-19, Zydus Wellness incurred a capital expenditure aggregating Rs 40.3 million.

As on 31 March 2020,the Company has four wholly owned subsidiary companies namely Zydus Wellness Products Limited (formely known as Zydus Nutritions Limited), Liva Nutritions Limited, Liva Investment Limited and Zydus Wellness International DMCC (Dubai). During the year under review, the name of Zydus Nutritions Limited was changed to Zydus Wellness Products Limited w.e.f June 4, 2019. Zydus Wellness International DMCC (Dubai) was incorporated during the year on May 28, 2019.

The ministry of Home Affairs vide order No.40-3/2020 dated March 24, 2020, notified first ever nationwide lockdown in India to contain the outbreak of Covid Pandemic. As a result, our operations were completely shut down during initial days of the Lockdown. However as stated before, operations are gradually moving towards near normalcy now and are in relatively better shape compared to what they were during the last week of March 20 and major part of April 20.

The Company has issued and allotted 21,22,000 and 38,46,000 Equity Shares of Rs 10 each to Promotors group and Qualified Institutional Placement on September 19, 2020 and September 28, 2020 at an issue price of Rs 1649 and Rs 1690 per Equty share respectively (induding premium of Rs 1639 and Rs 1680 per Equity Shares).

11 new products were launched in FY 2020-21 despite the pandemic induced setbacks. The Company launched Glucon-D ImmunoVolt and Immuno Fizz fortified with Vitamin C to boost the immunity for kids, which was supported with TV & digital media activities.

In FY'21-22, it relaunched Complan with pack design, enhanced proposition and improved taste. It launched Nutralite Professional Range & Everyuth New Body Lotion Range. Nutralite DoodhShakti Professional Pure Ghee & Butter was launched in Mar'22 to expand its presence in the institutional channel. Nutralite DoodhShakti dairy portfolio, which was impacted immediately after launch due to Cov id second wave, had started getting traction in second half of the year and was well supported with TV, Print and Digital campaigns. It launched Sugar Free D'Lite Cookies, Sugar Free D'Lite Chocolate Spread in the international markets. The Company expanded international footprint by entering new geographies as Hongkong, Lebanon, Zimbabwe, Muscat, Ethiopia, and Australia during 2021-22. It incorporated a new company in the name of Zydus Wellness (BD) Pvt Limited, as a wholly owned subsidiary company in Bangladesh. In FY'21-22, the Company inaugurated a new R&D set up in Ahmedabad as well.

During 2022-23, the Company launched new variants like Mango - in flavour and Kachha Mango - for Immunovolts. It launched new variant 'Mango blast' in Glucon-D and re-launched Nycil Body mist.

Zydus Wellness Share Price

Zydus Wellness share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Zydus Wellness Market Cap

Market capitalization of Zydus Wellness indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Zydus Wellness is valued compared to its competitors.

Zydus Wellness PE Ratio

Zydus Wellness PE ratio helps investors understand what is the market value of each stock compared to Zydus Wellness 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Zydus Wellness PEG Ratio

The PEG ratio of Zydus Wellness evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Zydus Wellness ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Zydus Wellness generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Zydus Wellness ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Zydus Wellness in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Zydus Wellness Total Debt

Total debt of Zydus Wellness shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Zydus Wellness Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Zydus Wellness compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Zydus Wellness CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Zydus Wellness over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Zydus Wellness Technical Analysis

Technical analysis of Zydus Wellness helps investors get an insight into when they can enter or exit the stock. Key components of Zydus Wellness Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Zydus Wellness shares often struggle to rise above due to selling pressure.

Zydus Wellness Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Zydus Wellness ’s financial health and profitability.

Zydus Wellness Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Zydus Wellness Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Zydus Wellness Financials

The financials of Zydus Wellness provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Zydus Wellness Profit and Loss Statements

The profit and loss statement of Zydus Wellness highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Zydus Wellness .

Zydus Wellness Balance Sheet

The balance sheet presents a snapshot of Zydus Wellness ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Zydus Wellness Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App